Also trades as: ACARIX.ST (STO) · $vol 0M
ACIXF OTC
Acarix AB (publ)
1W: +13.1%
1M: -7.1%
3M: -10.0%
YTD: -14.6%
1Y: -30.7%
$0.03
+0.00 (+13.14%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$29.2M
52W Range0.0199-0.0432
Volume19,000
Avg Volume19,140
Beta-0.22
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAamir Mahmood
Employees8
SectorHealthcare
IndustryMedical - Devices
IPO Date2022-12-07
Websiteacarix.com
Regus MalmOe
Malmö, SN 215 32
SE
Malmö, SN 215 32
SE
+45 44 41 44 41
About Acarix AB (publ)
Acarix AB (publ) operates as a medical technology enterprise, specializing in the development of swift, AI-powered diagnostic tools designed to exclude coronary artery disease (CAD). These solutions are deployed both within Sweden and on an international scale. The company's principal product is the CADScor System, an innovative diagnostic support device intended for immediate patient assessment. This system leverages precise acoustic measurements and sophisticated artificial intelligence algorithms to scrutinize blood flow within a patient's coronary arteries. Established in 2009, the firm maintains its corporate headquarters in Malmö, Sweden.
Latest News
No recent news
Recent Insider Trades
No insider trades found